Pharmaceutical - USA, Analgesia

Filter

Current filters:

USAAnalgesia

Popular Filters

Relmada appoints Julie Chen as Director of Finance and Operations

02-10-2014

US pain therapeutic specialists Relmada Therapeutics has appointed Julie Chen as its Director of Finance…

AnalgesiaBoardroomPharmaceuticalRelmada TherapeuticsUSA

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

22-09-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, has given notice to CRC European Loan…

AnalgesiaExparelFinancialPacira PharmaceuticalsPharmaceuticalSkyepharmaUKUSA

US DEA publishes final rule to reschedule hydrocodone combination products

US DEA publishes final rule to reschedule hydrocodone combination products

22-08-2014

The US Drug Enforcement Administration (DEA) has today published in the Federal Register the Final Rule…

AnalgesiaPharmaceuticalRegulationUS Drug Enforcement AdministrationUSA

Prescription drug abuse affects one in four of Americans

Prescription drug abuse affects one in four of Americans

05-08-2014

One in four Americans admits that they have abused prescription drugs, according to a new national survey…

AnalgesiaEgalet CorporationHealthcareNational Centers for Disease Control and PreventionPharmaceuticalPrescription drug abusePurdue PharmaTarginiqUSA

FDA approves Purdue’s abuse-deterrent opioid Targiniq ER for pain-management

FDA approves Purdue’s abuse-deterrent opioid Targiniq ER for pain-management

25-07-2014

The US Food and Drug Administration has approved privately-held USA-based Purdue Pharma’s abuse-deterrent…

AlcoholsAnalgesiaChemistryNaloxonePharmaceuticalPurdue PharmaRegulationTarginiqUSA

SI Group acquires ibuprofen and antioxidants from Albemarle Corp

SI Group acquires ibuprofen and antioxidants from Albemarle Corp

17-04-2014

Family-owned US chemical developer and manufacturer SI Group has signed a deal to acquire the antioxidants,…

AlbemarleAnalgesiaibuprofenMergers & AcquisitionsPharmaceuticalUSA

Executive Q&A: Bob Radie, chief executive and president of Egalet

Executive Q&A: Bob Radie, chief executive and president of Egalet

11-04-2014

In an interview with The Pharma Letter, Egalet Corporation’s chief executive Bob Radie discusses the…

AnalgesiaChemistryChief executiveCombination productsEgalet CorpEgalet CorporationInterviewsPharmaceuticalSevere chronic painUSA

Study: Half of veterans prescribed medical opioids continue to use them chronically

Study: Half of veterans prescribed medical opioids continue to use them chronically

07-03-2014

A study of nearly 1 million veterans who receive opioids to treat painful conditions found that more…

AnalgesiaHealthcarePharmaceuticalResearchUSA

FDA says Durect’s pain relief drug Posidur needs additional safety studies

FDA says Durect’s pain relief drug Posidur needs additional safety studies

13-02-2014

US drugmaker Durect Corp says that the US Food and Drug Administration has issued a Complete Response…

AnalgesiaDurectPharmaceuticalPosidurRegulationUSA

Back to top